All Reports Events Blogs Videos
Showing 13 results
  • PEAK Matrix®
    Sep. 30, 2026

    Pharmaceutical enterprises are under growing pressure to improve R&D productivity as development costs rise, scientific and therapeutic complexity increases, and timelines remain long. At the same time, advances in AI, generative AI, agentic AI, scientific computing,…
  • Innovation Watch
    Sep. 28, 2026

    Agentic AI is becoming a significant driver for life sciences commercial organizations seeking to improve productivity, customer engagement, and decision-making across increasingly complex workflows. Commercial teams are exploring its use across product launch, pricing and market…
  • Tech Launch Perspective
    July 22, 2026

    Life sciences enterprises are moving beyond isolated generative AI pilots toward governed, multi-agent workflows that support clinical, commercial, and real-world activities. This shift is increasing demand for platforms that combine regulatory-grade data governance, enterprise interoperability, scalable…
  • Provider Recognition
    July 15, 2026

    Pharmaceutical enterprises are accelerating technology investments to modernize operations across the pharmaceutical value chain spanning drug discovery, clinical development, manufacturing, sales and marketing, supply chain and distribution, and pharmacovigilance. As AI, cloud, and data-driven capabilities become…
  • Technology Awareness Deep Dive
    June 29, 2026

    This report examines the evolution of data center cooling as it becomes a foundational enabler of AI-scale infrastructure by supporting the rapid growth of graphics processing unit-intensive workloads, High-performance Computing (HPC) workloads, and machine learning workloads. The…
  • Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…
  • PEAK Matrix®
    July 16, 2025

    In recent years, life sciences enterprises have reprioritized and overhauled their R&D investments. They now focus on streamlining their pipelines and shifting toward new and large molecules. This transformation has compelled aggressive cost containment initiatives, prompting…
  • Discovery
    March 04, 2025

    Discoveries focus on specific science and technology innovations that address today’s critical business issues and challenges. These brief yet detailed profiles highlight innovations across the world's leading companies, start-ups, universities, institutes, and the entire R&D ecosystem…
  • Discovery
    Jan. 31, 2025

    Discoveries focus on specific science and technology innovations that address today’s critical business issues and challenges. These brief yet detailed profiles highlight innovations across the world's leading companies, start-ups, universities, institutes, and the entire R&D ecosystem…
  • Blog
    Oct. 24, 2024

    Remember when we were all buzzing about the metaverse like it was going to redefine reality? Yeah, that was just two years ago!Fast forward to last year, and suddenly generative AI  (gen AI) has become the…